Facebook
phone-icon CALL

Same Day Appointments

Book Your Appointment

Schedule Your Appointment Online

Choose the day and time that suits you best with HEALOW, our secure, HIPAA-compliant online booking system.

Schedule Now
or

Request a Consultation

Our scheduling team will contact you to arrange your appointment at your convenience. We look forward to assisting you!

Request a Consult
Join our Mailing List
Book Your Appointment

SAME DAY APPOINTMENTS

Schedule Your Appointment Online

Choose the day and time that suits you best with HEALOW, our secure, HIPAA-compliant online booking system.

Schedule Now
or

Request a Consultation

Our scheduling team will contact you to arrange your appointment at your convenience. We look forward to assisting you!

Request a Consult
LOCATIONS

Family-Owned • Triple Board-Certified Expertise

×
LOCATIONS
Smiling woman showing results of fine line and wrinkle reduction.

Botox in Johns Creek by a Board-Certified Dermatologist

★ ★ ★ ★ ★

Barbara Miller - Go to reviews

Dr. Timani is caring and has a great bedside manner. I did not have to wait, very considerate and timely.

PATIENT REVIEWS

Before-and-after Botox for frown lines between the eyebrows, showing a smoother, more relaxed brow. Before-and-after Botox for a man's forehead lines, showing smoother skin above the brows. Before-and-after Botox for crow's feet, showing softer lines at the outer corners of the eyes when smiling. Before-and-after Botox for crow's feet, showing smoother skin around the outer eye. Copy  Before-and-after Botox for frown lines between the eyebrows, showing a smoother, more relaxed brow.

Indications, Important Safety Information and Prescribing Information

Toggle

All images © 2020 Allergan

Indications, Important Safety Information and Prescribing Information

BOTOX® Cosmetic (onabotulinumtoxinA) Important Information

Indications

BOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of:

- Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity

- Moderate to severe lateral canthal lines associated with orbicularis oculi activity

- Moderate to severe forehead lines associated with frontalis activity

IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING

WARNING: DISTANT SPREAD OF TOXIN EFFECT

Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.

CONTRAINDICATIONS

BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation.

WARNINGS AND PRECAUTIONS

Lack of Interchangeability Between Botulinum Toxin Products

The potency units of BOTOX® Cosmetic are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of BOTOX® Cosmetic cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method.

Spread of Toxin Effect

Please refer to Boxed Warning for Distant Spread of Toxin Effect.

No definitive serious adverse event reports of distant spread of toxin effect associated with dermatologic use of BOTOX® Cosmetic at the labeled dose of 20 Units (for glabellar lines), 24 Units (for lateral canthal lines), 40 Units (for forehead lines with glabellar lines), 44 Units (for simultaneous treatment of lateral canthal lines and glabellar lines), and 64 Units (for simultaneous treatment of lateral canthal lines, glabellar lines, and forehead lines) have been reported. Patients or caregivers should be advised to seek immediate medical care if swallowing, speech, or respiratory disorders occur.

Serious Adverse Reactions With Unapproved Use

Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received BOTOX® injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of BOTOX® to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of BOTOX®. The safety and effectiveness of BOTOX® for unapproved uses have not been established.

Hypersensitivity Reactions

Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such reactions occur, further injection of BOTOX® Cosmetic should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined.

Cardiovascular System

There have been reports following administration of BOTOX® of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. Use caution when administering to patients with pre-existing cardiovascular disease.

Increased Risk of Clinically Significant Effects With Pre-existing Neuromuscular Disorders

Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia, and respiratory compromise from onabotulinumtoxinA (see Warnings and Precautions).

Dysphagia and Breathing Difficulties

Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning).

Pre-existing Conditions at the Injection Site

Caution should be used when BOTOX® Cosmetic treatment is used in the presence of inflammation at the proposed injection site(s) or when excessive weakness or atrophy is present in the target muscle(s).

Dry Eye in Patients Treated With BOTOX® Cosmetic

There have been reports of dry eye associated with BOTOX® Cosmetic injection in or near the orbicularis oculi muscle. If symptoms of dry eye (eg, eye irritation, photophobia, or visual changes) persist, consider referring patients to an ophthalmologist.

Human Albumin and Transmission of Viral Diseases

This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, CJD or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products.

ADVERSE REACTIONS

The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for glabellar lines were eyelid ptosis (3%), facial pain (1%), facial paresis (1%), and muscular weakness (1%).

The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for lateral canthal lines was eyelid edema (1%).

The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for forehead lines with glabellar lines were headache (9%), brow ptosis (2%), and eyelid ptosis (2%).

DRUG INTERACTIONS

Co-administration of BOTOX® Cosmetic and aminoglycosides or other agents interfering with neuromuscular transmission (eg, curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Use of anticholinergic drugs after administration of BOTOX® Cosmetic may potentiate systemic anticholinergic effects.

The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by

administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.

Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of BOTOX® Cosmetic.

USE IN SPECIFIC POPULATIONS

There are no studies or adequate data from postmarketing surveillance on the developmental risk associated with use of BOTOX® Cosmetic in pregnant women. There are no data on the presence of BOTOX® Cosmetic in human or animal milk, the effects on the breastfed child, or the effects on milk production.

Please see BOTOX® Cosmetic full Prescribing Information including Boxed Warning and Medication Guide.

Refresh Your Look Without Losing Your Expression


You want to look rested and refreshed, not frozen. Maybe forehead lines, frown lines, or crow's feet are becoming more noticeable, and you're wondering whether Botox can help without changing how you look.


At Johns Creek Dermatology, every Botox and wrinkle relaxer treatment is personally performed by Dr. Shereen Timani, a triple board-certified dermatologist. She considers how your face moves, where lines form, and how much treatment you need, with the goal of softening wrinkles while preserving your natural expressions.


We offer Botox®, Dysport®, and Xeomin®. Most patients can return to their usual activities right away, although temporary redness, swelling, or bruising at the injection sites may occur.


We welcome patients from Peachtree Corners, Suwanee, Duluth, and surrounding North Atlanta communities. We also participate in the Allē Rewards program for eligible treatments.


Call (770) 771-6591 or schedule your consultation online.




Why Patients Trust Johns Creek Dermatology for Botox


Every Injection by Dr. Timani

Dr. Shereen Timani personally performs every Botox, Dysport, and Xeomin treatment. Injections are never delegated to another provider.  


A Plan Based on How Your Face Moves

Muscle strength, expression patterns, and how you've responded to past treatments all affect where and how much product is used. Dr. Timani tailors each treatment rather than following a standard formula.


Transparent, Unit-Based Pricing

You pay only for the units you receive, with no flat-rate packages. The number of units varies by treatment area and individual anatomy, and Dr. Timani explains her recommendation before treatment.


Products Prepared to Manufacturer Standards

Each product is handled and prepared according to the manufacturer's instructions, using appropriate sterile technique.


Time for Your Questions

First visit or fifth, your consultation is never rushed. We take time to understand your goals and explain what to expect..




Beyond Wrinkle Reduction


We go beyond the basics to deliver results that look effortless and feel empowering. Whether you're new to Botox®, Dysport®, and Xeomin® or exploring advanced techniques, here's what injectables can do for you:


Botox®, Dysport®, and Xeomin® are FDA-approved for specific cosmetic uses, although their approved indications differ. Some treatments below involve off-label techniques or treatment areas. Dr. Timani will explain which product may be appropriate for your concerns and what results you can realistically expect.


Forehead Lines, Frown Lines & Crow's Feet

These are among the most common reasons patients choose wrinkle relaxers. By temporarily relaxing the muscles responsible for expression lines, treatment can soften their appearance while aiming to preserve natural facial movement.


Masseter Botox for Jaw Slimming

For patients with enlarged jaw muscles, masseter injections may gradually soften the appearance of a wide or square lower face. This is an off-label use, and suitability depends on your facial structure.


Lip Flip (Non-Surgical Lip Enhancement)

A small amount of neurotoxin injected near the upper lip may allow it to roll outward slightly, making more of the lip visible. Results are subtle and don't add volume. Patients seeking greater fullness may prefer lip fillers.


Nefertiti Neck & Jawline Treatment

Botox Cosmetic is FDA-approved to temporarily improve the appearance of moderate to severe platysma bands in adults. The broader Nefertiti technique may involve off-label injection patterns to address selected jawline and neck concerns.


Results depend on your anatomy and skin quality, and treatment does not replace procedures designed to address significant skin laxity.


Pore & Oil Control (Microtox)

Microtox uses small, diluted doses of botulinum toxin delivered superficially through targeted injections or, when appropriate, a device such as Aquagold®.

This off-label technique may help reduce oiliness and the appearance of enlarged pores, although evidence is limited and results vary.


Redness & Flushing

For some patients experiencing persistent facial redness or flushing, intradermal Microtox may offer improvement.

This is an off-label approach with limited clinical evidence. It is not a standard first-line rosacea treatment or a cure, but may be considered alongside other rosacea treatments when appropriate.


Not every concern calls for a wrinkle relaxer. If your main concern is volume loss or deeper facial folds, dermal fillers may be more appropriate.




Book Your Botox®, Dysport®, or Xeomin® Consultation Today


Not sure which treatment or how much you need? You don’t have to decide before your visit. Dr. Timani will review your goals, explain your options, and recommend a plan that looks natural on you.


Call (770) 771-6591 or schedule your consultation online.


Our Johns Creek location welcomes patients from Peachtree Corners, Norcross, Suwanee, Duluth, Alpharetta, Roswell, and surrounding North Atlanta communities.




Botox Frequently Asked Questions


How does Botox work?

Botox and similar wrinkle relaxers temporarily relax the muscles responsible for expression lines. They work best on wrinkles caused by movement, such as frown lines and crow's feet, although some lines visible at rest may also soften.


What's the difference between Botox, Dysport, and Xeomin?

All three are botulinum toxin type A products, but they differ in formulation, approved uses, and dosing. Their units are not interchangeable. Dr. Timani will recommend a product based on your treatment area, medical history, and goals.


Will I look frozen or overdone?

That is a common concern, especially for first-time patients. Dr. Timani plans treatment conservatively, aiming to soften wrinkles while preserving natural expressions. She will discuss your preferences and explain what results are realistic.


Does Botox hurt?

Most patients describe a quick pinch. The needles are very fine, and injections usually take only a few minutes. Let us know if you're anxious about needles so we can discuss ways to make treatment more comfortable.


When will I see results, and how long do they last?

Many patients notice changes within a few days, with results generally developing over approximately two weeks. Effects commonly last around 3 to 4 months, although timing varies by product, treatment area, and individual response.


How many Botox units will I need?

The number depends on the treatment area, your muscle activity, and the product used. FDA-approved treatments have recommended dosing guidelines, and Dr. Timani will explain the treatment plan appropriate for you.


How much does Botox cost?

We use unit-based pricing rather than flat-rate treatment packages. Cost depends on the product and number of units needed, which Dr. Timani will review before treatment. We also participate in Allē Rewards for eligible treatments.


Is there downtime after Botox?

Most patients can return to their usual activities shortly after treatment. Temporary redness, swelling, tenderness, or bruising may occur at injection sites. Dr. Timani will provide instructions about activities and precautions following your appointment.


What are the possible side effects?

Temporary redness, swelling, bruising, or headache may occur. Less common effects include temporary eyelid or brow drooping.

Rare but serious complications are possible. Seek immediate medical attention if you experience difficulty breathing, swallowing, or speaking after treatment. Dr. Timani will review relevant risks before your injections.


Who should avoid Botox?

Botox Cosmetic should not be used by people with an infection at the proposed injection site or a known allergy to botulinum toxin products or their ingredients.

Treatment is generally avoided during pregnancy and breastfeeding because safety information is limited. Certain neuromuscular conditions may increase the risk of complications and require careful medical evaluation.

Tell Dr. Timani about your medical history, medications, and previous injectable treatments during your consultation.


Can men get Botox?

Yes. Men commonly choose wrinkle relaxers to soften forehead lines, frown lines, and crow's feet. Treatment is planned around individual facial anatomy, muscle strength, and the degree of movement reduction desired.


Is there a right age to start Botox?

There is no single ideal age for adults. Some patients begin when expression lines first become bothersome, while others wait until later. Dr. Timani considers your skin, facial movement, and treatment goals rather than recommending injections based on age alone.


What's the difference between Botox and dermal fillers?

Botox temporarily relaxes muscles that cause expression lines, while dermal fillers can restore lost volume and soften certain folds. Depending on your concerns, one treatment or a combination may be appropriate.




RESOURCES

Botox | Dysport | Xeomin

Indications, Important Safety Information and Prescribing Information

Toggle

All images © 2020 Allergan

Indications, Important Safety Information and Prescribing Information

BOTOX® Cosmetic (onabotulinumtoxinA) Important Information

Indications

BOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of:

- Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity

- Moderate to severe lateral canthal lines associated with orbicularis oculi activity

- Moderate to severe forehead lines associated with frontalis activity

IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING

WARNING: DISTANT SPREAD OF TOXIN EFFECT

Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.

CONTRAINDICATIONS

BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation.

WARNINGS AND PRECAUTIONS

Lack of Interchangeability Between Botulinum Toxin Products

The potency units of BOTOX® Cosmetic are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of BOTOX® Cosmetic cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method.

Spread of Toxin Effect

Please refer to Boxed Warning for Distant Spread of Toxin Effect.

No definitive serious adverse event reports of distant spread of toxin effect associated with dermatologic use of BOTOX® Cosmetic at the labeled dose of 20 Units (for glabellar lines), 24 Units (for lateral canthal lines), 40 Units (for forehead lines with glabellar lines), 44 Units (for simultaneous treatment of lateral canthal lines and glabellar lines), and 64 Units (for simultaneous treatment of lateral canthal lines, glabellar lines, and forehead lines) have been reported. Patients or caregivers should be advised to seek immediate medical care if swallowing, speech, or respiratory disorders occur.

Serious Adverse Reactions With Unapproved Use

Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received BOTOX® injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of BOTOX® to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of BOTOX®. The safety and effectiveness of BOTOX® for unapproved uses have not been established.

Hypersensitivity Reactions

Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such reactions occur, further injection of BOTOX® Cosmetic should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined.

Cardiovascular System

There have been reports following administration of BOTOX® of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. Use caution when administering to patients with pre-existing cardiovascular disease.

Increased Risk of Clinically Significant Effects With Pre-existing Neuromuscular Disorders

Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia, and respiratory compromise from onabotulinumtoxinA (see Warnings and Precautions).

Dysphagia and Breathing Difficulties

Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning).

Pre-existing Conditions at the Injection Site

Caution should be used when BOTOX® Cosmetic treatment is used in the presence of inflammation at the proposed injection site(s) or when excessive weakness or atrophy is present in the target muscle(s).

Dry Eye in Patients Treated With BOTOX® Cosmetic

There have been reports of dry eye associated with BOTOX® Cosmetic injection in or near the orbicularis oculi muscle. If symptoms of dry eye (eg, eye irritation, photophobia, or visual changes) persist, consider referring patients to an ophthalmologist.

Human Albumin and Transmission of Viral Diseases

This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, CJD or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products.

ADVERSE REACTIONS

The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for glabellar lines were eyelid ptosis (3%), facial pain (1%), facial paresis (1%), and muscular weakness (1%).

The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for lateral canthal lines was eyelid edema (1%).

The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for forehead lines with glabellar lines were headache (9%), brow ptosis (2%), and eyelid ptosis (2%).

DRUG INTERACTIONS

Co-administration of BOTOX® Cosmetic and aminoglycosides or other agents interfering with neuromuscular transmission (eg, curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Use of anticholinergic drugs after administration of BOTOX® Cosmetic may potentiate systemic anticholinergic effects.

The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by

administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.

Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of BOTOX® Cosmetic.

USE IN SPECIFIC POPULATIONS

There are no studies or adequate data from postmarketing surveillance on the developmental risk associated with use of BOTOX® Cosmetic in pregnant women. There are no data on the presence of BOTOX® Cosmetic in human or animal milk, the effects on the breastfed child, or the effects on milk production.

Please see BOTOX® Cosmetic full Prescribing Information including Boxed Warning and Medication Guide.

Call us to schedule an appointment
★ ★ ★ ★ ★

Barbara Miller - Go to reviews

Dr. Timani is caring and has a great bedside manner. I did not have to wait, very considerate and timely.

PATIENT REVIEWS

ABD-Certification ABD-Certification ABD-Certification

JOIN OUR MAILING LIST

×

Thank you for signing up.

Send

Scroll-to-top